1 Johnson And Johnson Plz
New Brunswick, New Jersey 08933-0001
Phone: 17325242455
www.jnj.com
Johnson & Johnson (NYSE: JNJ) will participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC) on Wednesday, May 29th, at the New York Hilton Midtown, New York, NY. Joaquin Duato, Chairman and Chief Executive Officer will represent the Company in a session scheduled at 1:30 pm (Eastern Time). This live audio webcast will be available to investors and other interested parties Jetzt den vollständigen Artikel lesen
ArriVent BioPharma, Inc. appoints Kristine Peterson, a seasoned biopharmaceutical executive, to its Board of Directors. With over 30 years of industry experience, including leadership roles at major companies like Johnson & Johnson and Bristol-Myers Squibb, Peterson''s expertise will be important as ArriVent advances the development of firmonertinib for non-small cell lung cancer. Her track record of successful product launches and commercialization efforts makes her a valuable addition to the team, aiming to maximize the potential of ArriVent''s pipeline and deliver transformative medicines to cancer patients in need.
No summary available.
In February, I recommended five one-month momentum plays to buy as Bitcoin ( BTC-USD ) prices surged. The world’s largest cryptocurrency is a surprisingly good gauge of bubbly investor sentiment, and our writers at InvestorPlace.com had found several strong candidates to ride the market higher. Over the following month, these picks would rocket 47%, on average. Even assets with relatively weak fundamentals will go up if investors are bullish enough. Ticker Name 18-Feb Price 18-Mar Price Change PLUG Plug Power $ 4.00 $3.30 -15.9% SOUN SoundHoundAI $3.80 $8.90 133.2% NVDA Nvidia $726.10 $878.40 21.0% ETH Ethereum $2,881.30 $3,518.40 22.1% SOL-USD Solana $112.20 $196 74.7% Average Return 47.0% However, market sentiment has since soured. Bitcoin has lost 18% of its value since peaking in mid-March, and many smaller cryptocurrencies have fallen even further. There are other signs of growing market fear. On Monday, the CBOE Volatility Index (VIX) surged from its previous Friday low of $15 to over $19.50. (Since 2001, any time the VIX has risen more than 25% in a trading day, the market would go on to underperform its long-term average by an annualized 7.4% over the following 30 days).